Wernhart, Simon http://orcid.org/0000-0001-6732-0939
Michel, Lars
Carpinteiro, Alexander
Luedike, Peter
Rassaf, Tienush
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Accepted: 22 March 2024
First Online: 18 April 2024
Declarations
:
: PL received speaker honoraria and consulting fees from Astra Zeneca, Bayer, Pfizer, and Edwards Lifesciences, and research honoraria from Edwards Lifesciences. TR reports honoraria for lectures and advisory board activities for Bayer, AstraZeneca, Daiichi Sankyo, and Pfizer. TR is co-founder of Mycor, a start-up focussing on the development of algorithms to detect amyloidosis. None of these are related to the submitted manuscript. TR is a section editor for cardio-oncology for Current Heart Failure Reports. AC received consulting and/or lecture fees from Amgen, Janssen, Pfizer, and Takeda and travel and congress participation grants from Janssen; none of these are related to the submitted manuscript. All other authors have nothing to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Ethical approval was waived by the local Ethics Committee of University Duisburg-Essen in view of the retrospective nature of the study, and all the procedures being performed were part of the routine care.